Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 6 studies | 24% ± 6% | |
microglial cell | 3 studies | 16% ± 1% | |
GABAergic neuron | 3 studies | 32% ± 0% | |
glutamatergic neuron | 3 studies | 35% ± 3% | |
oligodendrocyte precursor cell | 3 studies | 24% ± 6% | |
astrocyte | 3 studies | 26% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 32% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1236.20 | 1445 / 1445 | 100% | 13.99 | 183 / 183 |
ovary | 100% | 1713.33 | 180 / 180 | 100% | 9.31 | 428 / 430 |
brain | 100% | 1030.58 | 2633 / 2642 | 100% | 9.32 | 704 / 705 |
lung | 99% | 965.15 | 575 / 578 | 100% | 9.86 | 1155 / 1155 |
breast | 100% | 1171.49 | 459 / 459 | 99% | 11.49 | 1110 / 1118 |
thymus | 100% | 2076.87 | 653 / 653 | 99% | 9.05 | 597 / 605 |
intestine | 100% | 1407.86 | 966 / 966 | 99% | 8.04 | 520 / 527 |
prostate | 100% | 1446.47 | 245 / 245 | 99% | 9.13 | 495 / 502 |
stomach | 100% | 917.50 | 359 / 359 | 98% | 9.02 | 281 / 286 |
pancreas | 100% | 781.77 | 327 / 328 | 98% | 6.72 | 175 / 178 |
bladder | 100% | 1551.62 | 21 / 21 | 97% | 7.31 | 491 / 504 |
uterus | 100% | 1941.14 | 170 / 170 | 97% | 7.80 | 446 / 459 |
kidney | 100% | 984.81 | 89 / 89 | 95% | 6.87 | 853 / 901 |
adrenal gland | 100% | 1240.42 | 258 / 258 | 94% | 5.93 | 216 / 230 |
skin | 100% | 1452.18 | 1809 / 1809 | 93% | 8.07 | 441 / 472 |
liver | 100% | 561.12 | 226 / 226 | 72% | 3.20 | 292 / 406 |
blood vessel | 100% | 1262.55 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1235.57 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.63 | 1 / 1 |
adipose | 100% | 1098.34 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 610.91 | 798 / 803 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 7.39 | 44 / 45 |
heart | 97% | 615.36 | 833 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 8.42 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 69% | 3.92 | 55 / 80 |
peripheral blood | 60% | 780.26 | 554 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0016020 | Cellular component | membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | DCAF17 |
Protein name | DDB1 and CUL4 associated factor 17 DDB1- and CUL4-associated factor 17 |
Synonyms | C2orf37 |
Description | FUNCTION: May function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. . |
Accessions | ENST00000539783.5 ENST00000339506.7 ENST00000436317.1 H7C244 ENST00000611110.4 [Q5H9S7-2] ENST00000431110.1 Q5H9S7 H0Y2X0 F5H7W1 H7C1H3 ENST00000375255.8 [Q5H9S7-1] |